Investor Briefing

RNS Number : 7880S

Avacta Group PLC

29 September 2014

 



29 September 2014

Avacta Group plc

("Avacta" or the "Group")

Investor Results Briefing

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces it will be hosting an investor results presentation on Thursday 16 October 2014 where Alastair Smith, CEO, Craig Slater, COO and Tim Sykes, CFO will present the Company's results for its financial year ended 31 July 2014.

The investor event, open to all investors, will be held from 16:30 at the Black Bar, Rocket, 6 Adams Court, EC2N 1DX followed by drinks and canapés.

For more information or to register to attend, contact Walbrook PR (contact details are below).

Enquiries:

Avacta Group plc Alastair Smith, Chief Executive Officer Tim Sykes, Chief Financial Officer	Tel:  [phone] www.avacta.com
Numis Securities Limited     Michael Meade / Freddie Barnfield - Nominated Adviser James Black - Corporate Broking	Tel:  [phone] www.numiscorp.com
Media Enquiries Walbrook PR Ltd Anna Dunphy / Mike Wort	Tel: [phone] [e-mail]

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

Avacta Analytical www.avactaanalytical.com	High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.
Avacta Animal Health www.avactaanimalhealth.com	Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.
Avacta Life Sciences www.avactalifesciences.com	Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

END

 

 

NRASEAFMMFLSESU